Skip to main content

TYVASO and TYVASO DPI are approved for the treatment of pulmonary hypertension associated with interstitial lung disease (PH-ILD; WHO Group 3) to improve the ability to exercise.

Skip to main content

HOW TYVASO WORKS

TYVASO is inhaled
directly to the lungs where it works to help open up the blood vessels

Group 4

HOW TYVASO WORKS

TYVASO is inhaled
directly to the lungs where it works to help open up the blood vessels

HOW TYVASO WORKS

TYVASO is inhaled directly to the lungs where it works to help open up the blood vessels

In the clinical study, patients taking TYVASO were more likely to experience cough, headache, and throat irritation/pain than they were to experience nausea and diarrhea. Learn more about managing the possible side effects of TYVASO.

TYVASO is offered in 2 delivery options: a dry powder inhaler (DPI) and a nebulizer. Be sure to talk with your doctor about which one is right for you.

“It's helping me feel better. It's helping me move better. And that is all that I can ask for.*”

— Sally, living with PH-ILD and taking TYVASO DPI
HEAR SALLY’S STORY

*Individual results may vary.

TYVASO may help you be more active.

TYVASO DPI may fit into your routine.